Potential antiatherosclerotic agents. 3. Substituted benzoic and nonbenzoic acid analogs of cetaben
作者:J. Donald Albright、Vern G. DeVries、Mila T. Du、Elwood E. Largis、Thomas G. Miner、Marvin F. Reich、Robert G. Shepherd
DOI:10.1021/jm00364a010
日期:1983.10
acid group of cetaben is replaced by carboxylate ester, carboxamide, or a variety of other substituent groups is described. Also reported are the syntheses of analogues in which the phenyl ring of cetaben is either modified by the presence of additional substituents or replaced entirely by another moiety. Structure-activity relationships of these compounds both as hypolipidemic agents and as inhibitors
描述了一系列类似物的合成,其中cetaben的羧酸基被羧酸酯,羧酰胺或各种其他取代基取代。还报道了类似物的合成,其中cetaben的苯环被其他取代基的存在修饰或被另一部分完全取代。讨论了这些化合物作为降血脂药和作为脂肪酰基辅酶A:胆固醇酰基转移酶(ACAT)抑制剂的结构活性关系。被设计为产生比西他本更好口服吸收的化合物的类似物合成未能产生任何具有增强生物活性的同类物。相反,针对酸度与西他本相似的非羧酸的类似物合成产生了非常活跃的磺酰胺类。